8-K - AbCellera Biologics Inc. | StockGist

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment o

Management Change

Company. Dr. Lo joined the Board in December 2021 and served on the Audit and Nominating and Corporate Governance Committees. The Board would like to thank Dr. Lo for his leadership and service to the Company

9.01

Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release issued by AbCellera Biologics Inc. on November 10, 2025. 104 Cover Pag

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1